Mark Damante, MD (@markd_jr) 's Twitter Profile
Mark Damante, MD

@markd_jr

PGY-4 @NeurosurgeryOSU | Neurosurgical Oncology, Immuno-oncology, Drug Delivery

ID: 391107847

linkhttps://pubmed.ncbi.nlm.nih.gov/?term=Damante+M# calendar_today15-10-2011 02:09:43

4,4K Tweet

465 Takipçi

851 Takip Edilen

Columbus Blue Jackets (@bluejacketsnhl) 's Twitter Profile Photo

We're proud to partner with the Ohio Sled Hockey program to provide individuals with physical disabilities the opportunity to play our amazing game! Learn more about them at ohiosledhockey.org 🏒 Vorys | #HockeyIsForEveryone

Ohio State Neurosurgery Residency (@neurosurgeryosu) 's Twitter Profile Photo

Couldn’t be more excited to announce our 2025 match results! Welcome to Ohio State Neurosurgery Chandler Berke, Jakob Jarmula, Spencer Raub, and Bradley Wilhelmy!

Couldn’t be more excited to announce our 2025 match results! Welcome to Ohio State Neurosurgery Chandler Berke, Jakob Jarmula, Spencer Raub, and Bradley Wilhelmy!
IU Neurosurgery (@neurosurgery_iu) 's Twitter Profile Photo

Congratulations to our new Hoosiers! Guilherme Finger from Universidade de Caxias do Sul (UCS) Faculdade de Medicina, Brazil, and Raj Lavadi from Vydehi Institute, Bangalore, India.

Congratulations to our new Hoosiers! Guilherme Finger from Universidade de Caxias do Sul (UCS) Faculdade de Medicina, Brazil, and Raj Lavadi from Vydehi Institute, Bangalore, India.
Ohio State Neurosurgery Residency (@neurosurgeryosu) 's Twitter Profile Photo

Honored to have Mr Nick Thomas from King’s Hospital in London join us as visiting professor for our 2025 John McGregor MD lectureship! Mr Thomas was a former fellow at OSU and gave an outstanding talk on complex craniocervical junction pathology!

Honored to have Mr Nick Thomas from King’s Hospital in London join us as visiting professor for our 2025 John McGregor MD lectureship! Mr Thomas was a former fellow at OSU and gave an outstanding talk on complex craniocervical junction pathology!
IU Neurosurgery (@neurosurgery_iu) 's Twitter Profile Photo

Meet 1 of our incoming residents, Dr. Guilherme Finger! From pro basketball to nearly 60 neurosurgery publications, his journey spans from Brazil 🇧🇷, where he completed neurosurgery residency, to Ohio State—and now Indy! Welcome to the team, Dr. Finger! #Neurosurgery #Match2024

Meet 1 of our incoming residents, Dr. Guilherme Finger! From pro basketball to nearly 60 neurosurgery publications, his journey spans from Brazil 🇧🇷, where he completed neurosurgery residency, to Ohio State—and now Indy! Welcome to the team, Dr. Finger!  #Neurosurgery #Match2024
Pelotonia Institute for Immuno-Oncology (@ohiostatepiio) 's Twitter Profile Photo

🎉 We’re celebrating IND approval for the #first_in_human #PIIO-1 trial — a groundbreaking #CAR_T #CellTherapy for recurrent #glioblastoma!🧠 This novel approach targets GARP & delivers engineered #Tcells directly into the tumor. A major milestone for #GBM research and

🎉 We’re celebrating IND approval for the #first_in_human #PIIO-1 trial — a groundbreaking #CAR_T #CellTherapy for recurrent #glioblastoma!🧠 This novel approach targets GARP & delivers engineered #Tcells directly into the tumor. A major milestone for #GBM research and
Zihai Li, MD, PhD (@zihai) 's Twitter Profile Photo

“Our novel CAR-T clinical trial has officially received IRB approval today. Grateful to the team for their hard work and dedication. Onward to the next phase! #ClinicalResearch #IRBApproval #TranslationalScience The James Pelotonia Institute for Immuno-Oncology

Zihai Li, MD, PhD (@zihai) 's Twitter Profile Photo

A milestone in our fight against cancer: today, the 1st patient received the anti-#GARP CAR-T therapy for #GBM. Immense gratitude to this courageous patient and to the incredible team whose dedication made it possible. Pelotonia Institute for Immuno-Oncology The James Ohio State Neurosurgery Residency The Ohio State University Wexner Medical Center

A milestone in our fight against cancer: today, the 1st patient received the anti-#GARP CAR-T therapy for #GBM. Immense gratitude to this courageous patient and to the incredible team whose dedication made it possible.  <a href="/OhioStatePIIO/">Pelotonia Institute for Immuno-Oncology</a> <a href="/OSUCCC_James/">The James</a> <a href="/NeurosurgeryOSU/">Ohio State Neurosurgery Residency</a> <a href="/OSUWexMed/">The Ohio State University Wexner Medical Center</a>
Pelotonia Institute for Immuno-Oncology (@ohiostatepiio) 's Twitter Profile Photo

#PIIO-1 (Anti-#GARP #CAR_T) is a milestone worth celebrating together. Grateful to the courageous patient and to everyone who made this possible. Here’s to changing lives. Zihai Li, MD, PhD Li Lab, #OSUCCC #CELL_THERAPY_LAB #Gratitude

#PIIO-1 (Anti-#GARP #CAR_T) is a milestone worth celebrating together. Grateful to the courageous patient and to everyone who made this possible. Here’s to changing lives. <a href="/Zihai/">Zihai Li, MD, PhD</a> Li Lab, #OSUCCC #CELL_THERAPY_LAB #Gratitude
Guilherme Finger (@guilherme_fngr) 's Twitter Profile Photo

Honored and proud to have spent the last 3 y at OSU. Over 900 surgeries, impactful research, and exposure to cutting-edge techniques that are redefining neurosurgery. Grateful to my mentors, residents and co-fellows. Thank you for the help and friendship. Go Bucks!->Go Hoosiers!

Honored and proud to have spent the last 3 y at OSU. Over 900 surgeries, impactful research, and exposure to cutting-edge techniques that are redefining neurosurgery. Grateful to my mentors, residents and co-fellows. Thank you for the help and friendship. Go Bucks!-&gt;Go Hoosiers!
Journal of Neuro-Oncology (@jneurooncol) 's Twitter Profile Photo

Kreatsoulas et al. Ohio State Neurosurgery Residency Russell Lonser, M.D. developed and validated the MBLS to predict 90-day post-op survival in brain metastasis, offering a practical tool for pre-op risk stratification based on imaging and clinical factors. #JNO Read more:link.springer.com/article/10.100…

Kreatsoulas et al. <a href="/NeurosurgeryOSU/">Ohio State Neurosurgery Residency</a> <a href="/RussellLonser/">Russell Lonser, M.D.</a> developed and validated the MBLS to predict 90-day post-op survival in brain metastasis, offering a practical tool for pre-op risk stratification based on imaging and clinical factors. #JNO

Read more:link.springer.com/article/10.100…
Gene Therapy Institute at Ohio State University (@osugenetherapy) 's Twitter Profile Photo

🧬We are excited to host the Second Annual #GeneTherapy Symposium with the Jerry R. Mendell Center for Gene Therapy in April 2026. Additional details coming soon!

🧬We are excited to host the Second Annual #GeneTherapy Symposium with the Jerry R. Mendell Center for Gene Therapy in April 2026. Additional details coming soon!